ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995